Explore 3 Stock Ideas & Industry Insights Download Free Report

Avant Brands Inc

Healthcare US AVTBF

0.4426USD
0.005(1.14%)

Last update at 2026-06-03T13:31:00Z

Day Range

0.440.44
LowHigh

52 Week Range

0.380.84
LowHigh

Fundamentals

  • Previous Close 0.44
  • Market Cap6.41M
  • Volume32
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-5.99867M
  • Revenue TTM34.35M
  • Revenue Per Share TTM3.02
  • Gross Profit TTM 3.09M
  • Diluted EPS TTM-0.79

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-11-30 2024-11-30 2023-11-30 2022-11-30 2021-11-30
Type yearly yearly yearly yearly yearly
Date 2025-11-30 2024-11-30 2023-11-30 2022-11-30 2021-11-30
Income before tax -9.91600M -25.83200M -2.99600M -6.25400M -12.33000M
Minority interest - 0.00000M 0.10M -0.92400M -
Net income -9.88000M -22.55400M -5.07000M -7.54200M -11.23400M
Selling general administrative 6.58M 8.73M 10.00M 9.46M 6.38M
Selling and marketing expenses - - - - -
Gross profit 4.57M -1.67600M 12.43M 3.91M 1.90M
Reconciled depreciation 0.56M 4.79M 6.29M 4.37M 1.60M
Ebit - - - -8.54200M -5.50100M
Ebitda - - - -1.88800M -9.57900M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -6.15600M -14.14300M -1.45100M -8.54200M -3.86200M
Other operating expenses - - - - -
Interest expense 0.82M 1.51M 1.23M 0.00000M 1.15M
Tax provision -0.03600M -3.27800M 2.18M 0.36M -1.19900M
Interest income 0.00900M 0.00000M - - -
Net interest income -1.90100M -1.58400M -1.27500M -0.03700M -1.14800M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - 0.36M -1.19900M
Total revenue 35.90M 35.80M 26.34M 20.15M 9.50M
Total operating expenses 42.05M 49.95M 27.80M 28.69M 13.36M
Cost of revenue 31.33M 37.48M 13.91M 16.23M 7.60M
Total other income expense net -1.85900M -10.10500M -0.27000M 2.33M -7.32000M
Discontinued operations - - - - -0.10300M
Net income from continuing ops -9.88000M -22.55400M -5.17400M -6.61800M -11.13100M
Net income applicable to common shares - - - -7.54200M -11.23400M
Preferred stock and other adjustments - - - - -
Breakdown 2025-11-30 2024-11-30 2023-11-30 2022-11-30 2021-11-30
Type yearly yearly yearly yearly yearly
Date 2025-11-30 2024-11-30 2023-11-30 2022-11-30 2021-11-30
Total assets 49.24M 59.47M 82.55M 67.03M 50.57M
Intangible assets 1.04M 1.42M 2.06M 3.87M 3.20M
Earning assets - - - - -
Other current assets - - - 4.15M 1.95M
Total liab 24.44M 26.62M 33.22M 18.79M 2.70M
Total stockholder equity 24.80M 32.85M 49.33M 43.92M 47.87M
Deferred long term liab - - - - -
Other current liab - - - - -
Common stock - - - 94.54M 92.74M
Capital stock 110.91M 109.80M 104.57M 94.54M 92.74M
Retained earnings -97.89000M -88.01000M -65.91300M -59.28900M -51.74700M
Other liab - - - 13.09M -
Good will 0.00000M 0.00000M 6.02M 6.02M 0.18M
Other assets - - - - -
Cash 1.49M 1.74M 0.77M 6.76M 14.31M
Cash and equivalents - - - - -
Total current liabilities 12.85M 14.97M 21.22M 3.29M 2.40M
Current deferred revenue - - - - -
Net debt 2.42M 5.85M 6.14M - -
Short term debt - - - - -
Short long term debt 2.41M 4.61M 6.92M - -
Short long term debt total - - - - -
Other stockholder equity - - - - -
Property plant equipment - - - 28.65M 17.07M
Total current assets 20.84M 26.23M 35.19M 27.49M 26.17M
Long term investments - - - 1.00M 3.95M
Net tangible assets - - - 34.03M 44.49M
Short term investments - 0.00000M 0.02M 0.02M 0.18M
Net receivables 6.16M 6.75M 2.96M 4.41M 2.35M
Long term debt 1.49M 2.98M - - -
Inventory 12.22M 16.69M 28.94M 10.46M 6.17M
Accounts payable 8.00M 7.36M 13.02M 2.68M 1.61M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 28.40M 33.24M 47.36M 39.54M 24.40M
Capital lease obligations 11.40M 10.20M 10.04M 3.01M 0.62M
Long term debt total - - - - -
Breakdown 2025-11-30 2024-11-30 2023-11-30 2022-11-30 2021-11-30
Type yearly yearly yearly yearly yearly
Date 2025-11-30 2024-11-30 2023-11-30 2022-11-30 2021-11-30
Investments 0.00000M 0.02M 0.00000M -1.80200M -1.55500M
Change to liabilities - - - 0.21M -0.41600M
Total cashflows from investing activities - - - -3.09500M -1.64900M
Net borrowings -6.00700M -1.23400M -4.21000M -0.69500M -6.75300M
Total cash from financing activities -6.21400M 0.54M -4.37800M -0.99300M 20.96M
Change to operating activities - - - -2.74200M -1.17100M
Net income -9.88000M -22.55400M -5.07000M -7.54200M -11.23400M
Change in cash -0.25500M 0.97M -5.99200M -7.54900M 13.69M
Begin period cash flow 1.74M 0.77M 6.76M 14.31M 0.62M
End period cash flow 1.49M 1.74M 0.77M 6.76M 14.31M
Total cash from operating activities 5.75M 0.51M 5.41M -3.46100M -5.62300M
Issuance of capital stock 0.00000M 2.37M 0.00000M 0.00000M 25.40M
Depreciation 0.56M 4.79M 6.29M 1.88M 1.02M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory 5.32M -4.65700M -9.18200M -2.09400M -2.61700M
Change to account receivables - - - -1.01200M -0.28100M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - -0.29800M -1.55600M
Change to netincome - - - 7.84M 9.08M
Capital expenditures 0.03M 0.11M 3.56M 1.44M 0.59M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 7.37M -10.95700M 2.82M -5.63900M -4.48500M
Stock based compensation 0.91M 0.75M 2.96M 3.60M -
Other non cash items 5.27M 19.61M -2.11600M 1.26M 1.38M
Free cash flow 5.71M 0.40M 1.85M -4.90400M -6.21700M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AVTBF
Avant Brands Inc
0.005 1.14% 0.44 - - 0.19 0.44 0.69 16.06
ZTS
Zoetis Inc
1.20 1.57% 77.59 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR
0.58 1.91% 31.01 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
- -% 153.91 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG
-0.79 1.89% 40.92 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

Profile

Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada. The company offers recreational cannabis products under the BLK MKT, Tenzo, Cognoscente, Treehugger, Pristine, and Flowr brands. It also provides medical cannabis products under the GreenTec brand. The company distributes cannabis through medical and recreational sales channels, as well as an e-commerce website. It also exports its products through the wholesale channel. The company was formerly known as GTEC Holdings Ltd. and changed its name to Avant Brands Inc. in July 2021. Avant Brands Inc. is headquartered in Kelowna, Canada.

Avant Brands Inc

1632 Dickson Avenue, Kelowna, BC, Canada, V1Y 7T2

Key Executives

Name Title Year Born
Mr. Norton Singhavon Founder, CEO & Director NA
Mr. Michael Blady B.Sc Co-Founder, Sec. & Director 1983
Mr. David Lynn Chief Operating Officer NA
Mr. Matthew Whitt Chief Financial Officer NA
Mr. Adil Hirji Director of Marketing NA
Mr. Kyle Marko Sales Mang. NA
Mr. Chris Pearson Director of Sales NA
Mr. Jeremy Christopher Wright C.M.A., CPA, CMA, CPA Consultant 1974
Mr. David Buckle Head of Cultivation NA
Mr. Michael Blady B.Sc Co-Founder & Director 1984

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions